MétaCan
Menu
Back to cohort
Record W3098597689 · doi:10.1002/jimd.12332

Consensus guidelines for the diagnosis and management of pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency

2020· review· en· W3098597689 on OpenAlexaff
Curtis R. Coughlin, Laura A. Tseng, José E. Abdenur, Catherine Ashmore, François Boemer, Levinus A. Bok, Monica Boyer, Daniela Buhaş, Peter T. Clayton, Anibh M. Das, Hanka Dekker, Athanasios Evangeliou, François Feillet, Emma Footitt, Sídney M. Gospe, Hans Hartmann, Majdi Kara, Erle Kristensen, Joy Lee, R. Lilje, Nicola Longo, Roelineke J. Lunsing, Philippa B. Mills, Maria Papadopoulou, Phillip L. Pearl, Flávia Piazzon, Barbara Plecko, Arushi Gahlot Saini, Saikat Santra, Damayanti Rusli Sjarif, Sylvia Stöckler‐Ipsiroglu, Pasquale Striano, Johan L.K. Van Hove, Nanda M. Verhoeven‐Duif, Frits A. Wijburg, Sameer M. Zuberi, Clara van Karnebeek

Bibliographic record

VenueJournal of Inherited Metabolic Disease · 2020
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMetabolism and Genetic Disorders
Canadian institutionsUniversity of British ColumbiaMcGill University Health CentreBC Children's HospitalMontreal Children's Hospital
FundersUCB PharmaEisaiMinistero dell’Istruzione, dell’Università e della RicercaUniversity College LondonNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchEpilepsy Research UKNHS Health ScotlandZogenixNational Institute for Health and Care ResearchDravet Syndrome UKTenovusGW Pharmaceuticals
KeywordsMedicineEpilepsyPyridoxinePharmacologyPediatricsInternal medicinePsychiatry

Abstract

fetched live from OpenAlex

Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is an autosomal recessive condition due to a deficiency of α-aminoadipic semialdehyde dehydrogenase, which is a key enzyme in lysine oxidation. PDE-ALDH7A1 is a developmental and epileptic encephalopathy that was historically and empirically treated with pharmacologic doses of pyridoxine. Despite adequate seizure control, most patients with PDE-ALDH7A1 were reported to have developmental delay and intellectual disability. To improve outcome, a lysine-restricted diet and competitive inhibition of lysine transport through the use of pharmacologic doses of arginine have been recommended as an adjunct therapy. These lysine-reduction therapies have resulted in improved biochemical parameters and cognitive development in many but not all patients. The goal of these consensus guidelines is to re-evaluate and update the two previously published recommendations for diagnosis, treatment, and follow-up of patients with PDE-ALDH7A1. Members of the International PDE Consortium initiated evidence and consensus-based process to review previous recommendations, new research findings, and relevant clinical aspects of PDE-ALDH7A1. The guideline development group included pediatric neurologists, biochemical geneticists, clinical geneticists, laboratory scientists, and metabolic dieticians representing 29 institutions from 16 countries. Consensus guidelines for the diagnosis and management of patients with PDE-ALDH7A1 are provided.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.025
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.014
Threshold uncertainty score0.049

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.025
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.004
Bibliometrics0.0040.003
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0060.002
Research integrity0.0080.006
Insufficient payload (model declined to judge)0.0060.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.066
GPT teacher head0.357
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations118
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Inherited Metabolic DiseaseSame topicMetabolism and Genetic DisordersFrench-language works237,207